WASHINGTON — U.S. health officials on Friday approved a closely watched Alzheimer’s drug that modestly slows the brain-robbing disease, albeit with potential safety risks that patients and their doctors will have to carefully weigh.
The drug, Leqembi, is the first that’s been convincingly…
Source: www.modernhealthcare.com – Read more
New Android Malware with factory reset resistance is affecting millions of devices: Here's what you need… – Moneycontrol.com
New Android Malware with factory reset resistance is affecting millions of devices: Here’s what you need… Moneycontrol.com
